Tags

Type your tag names separated by a space and hit enter

SARS-CoV-2: An immunogenetics call to arms.
Int J Immunogenet. 2020 Aug; 47(4):319-323.IJ

Abstract

Susceptibility to viral infection, development of immunity, response to treatment and patient clinical outcomes are all under the control of heritable factors in the host. In the context of the current SARS-Cov-2 pandemic, this review considers existing immunogenetic knowledge of virus-immune system interactions. A major focus is to highlight areas in which work is required in order to improve understanding of antiviral immune responses and to move towards improved patient management.

Authors+Show Affiliations

Transplant Immunology, Leeds Teaching Hospitals, Leeds, UK.Transplantation Laboratory, Manchester Royal Infirmary, Manchester, UK. Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

32654378

Citation

Clark, Brendan, and Kay Poulton. "SARS-CoV-2: an Immunogenetics Call to Arms." International Journal of Immunogenetics, vol. 47, no. 4, 2020, pp. 319-323.
Clark B, Poulton K. SARS-CoV-2: An immunogenetics call to arms. Int J Immunogenet. 2020;47(4):319-323.
Clark, B., & Poulton, K. (2020). SARS-CoV-2: An immunogenetics call to arms. International Journal of Immunogenetics, 47(4), 319-323. https://doi.org/10.1111/iji.12504
Clark B, Poulton K. SARS-CoV-2: an Immunogenetics Call to Arms. Int J Immunogenet. 2020;47(4):319-323. PubMed PMID: 32654378.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - SARS-CoV-2: An immunogenetics call to arms. AU - Clark,Brendan, AU - Poulton,Kay, Y1 - 2020/07/12/ PY - 2020/05/18/received PY - 2020/06/05/revised PY - 2020/06/09/accepted PY - 2020/7/13/pubmed PY - 2020/7/28/medline PY - 2020/7/13/entrez SP - 319 EP - 323 JF - International journal of immunogenetics JO - Int J Immunogenet VL - 47 IS - 4 N2 - Susceptibility to viral infection, development of immunity, response to treatment and patient clinical outcomes are all under the control of heritable factors in the host. In the context of the current SARS-Cov-2 pandemic, this review considers existing immunogenetic knowledge of virus-immune system interactions. A major focus is to highlight areas in which work is required in order to improve understanding of antiviral immune responses and to move towards improved patient management. SN - 1744-313X UR - https://www.unboundmedicine.com/medline/citation/32654378/SARS_CoV_2:_An_immunogenetics_call_to_arms_ L2 - https://doi.org/10.1111/iji.12504 DB - PRIME DP - Unbound Medicine ER -